SARS-CoV-2 seroprevalence in the city of Puerto Madryn: Underdiagnosis and relevance of children in the pandemic푸에르토 마드린 시의 SARS-CoV-2 혈청 유병률: 전염병에서 어린이의 진단 부족 및 관련성Article Published on 2022-03-142022-09-12 Journal: PLoS ONE [Category] MERS, SARS, 진단, 치료기술, [키워드] Administered age Asymptomatic case blood sample calculated children Cluster Community Comorbidity confidence interval COVID-19 cross-sectional demographics evaluate General population Health IgG antibody in vitro Infection infections Mild National Older pandemic participant prevalence of COVID-19 Probability progression proportion questionnaire reported Sample size SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 seroprevalence selected Seropositivity stratified study period study population subject Surveillance Symptom the spike protein to define total population was obtained with COVID-19 [DOI] 10.1371/journal.pone.0263679 PMC 바로가기 [Article Type] Article
Seroprevalence of COVID-19 infection among vaccine naïve population after the second surge (June 2020) in a rural district of South India: A community-based cross-sectional study남인도 농촌 지역에서 두 번째 급증(2020년 6월) 후 백신 경험이 없는 인구 사이에서 COVID-19 감염의 혈청 유병률: 지역 사회 기반 횡단면 연구Research Article Published on 2022-03-102022-09-12 Journal: PLoS ONE [Category] MERS, SARS, 진단, [키워드] 95% CI adjusted antibody conducted COVID-19 COVID-19 infection cross-sectional cross-sectional study determine District effort Elecsy family member FIVE Health herd immunity house IFR IgG IgM Immunity Infection naïve objective past population density positive COVID-19 presence of antibody Prevalence Protein Randomly Rate RBD Receptor-binding domain recruited relief Result Roche Rural health SARS CoV SARS CoV-2 SARS-CoV-2 self Seropositivity Seroprevalence Serosurvey significantly South south India Symptom tested the receptor-binding domain thought Vaccine [DOI] 10.1371/journal.pone.0265236 PMC 바로가기 [Article Type] Research Article
Seroprevalence, Waning and Correlates of Anti-SARS-CoV-2 IgG Antibodies in Tyrol, Austria: Large-Scale Study of 35,193 Blood Donors Conducted between June 2020 and September 2021오스트리아 티롤에서 항 SARS-CoV-2 IgG 항체의 혈청유병률, 감소 및 상관관계: 2020년 6월에서 2021년 9월 사이에 수행된 35,193명의 헌혈자에 대한 대규모 연구Article Published on 2022-03-092022-09-11 Journal: Viruses [Category] MERS, SARS, 진단, 치료법, [키워드] 95% CI analyzed anti-N IgG anti-S anti-S IgG anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody anti-spike IgG levels antibody antibody level antibody levels Blood blood donor Blood donors conducted declined General population IgG IgG level individual Infection median age nucleocapsid protein Nucleocapsid proteins performed reduced SARS-CoV-2 SARS-COV-2 infection Seropositivity Seroprevalence serum sample serum samples vaccinated individuals vaccination [DOI] 10.3390/v14030568 PMC 바로가기 [Article Type] Article
Neutralizing Antibody Activity Against the B.1.617.2 (delta) Variant Before and After a Third BNT162b2 Vaccine Dose in Hemodialysis Patients혈액 투석 환자에서 세 번째 BNT162b2 백신 접종 전후의 B.1.617.2(델타) 변이체에 대한 중화 항체 활성Article Published on 2022-03-042022-09-11 Journal: Frontiers in Immunology [Category] MERS, SARS, 변종, 진단, [키워드] activity addition Against Anti-RBD antibodies Anti-RBD antibody B.1.617.2 BNT162b2 correlation COVID-19 COVID-19 vaccination delta variant demonstrated determined by dialysis Epitopes Hemodialysis high risk Humoral immunity IgG IgG antibodies IgG antibody Immune escape Immunity immunocompromised individuals IQR Live virus median neutralization Neutralizing Neutralizing activity Patient SARS-CoV-2 SARS-CoV-2 epitope SARS-CoV-2 epitopes second vaccination seroconversion rate seroconverted Seropositivity severe COVID-19 significantly higher the strongest vaccination vaccine dose variant variants variants of concern was performed [DOI] 10.3389/fimmu.2022.840136 PMC 바로가기 [Article Type] Article
SARS-CoV-2 antibody prevalence among healthcare workers: A cross-sectional study at a quaternary healthcare center in Saudi Arabia의료 종사자 사이의 SARS-CoV-2 항체 유병률: 사우디 아라비아의 4차 의료 센터에서 단면 연구Article Published on 2022-03-012022-09-11 Journal: Journal of infection and public health [Category] MERS, SARS, 진단, 치료기술, [키워드] carried city conditions conducted Control COVID-19 cross-sectional cross-sectional study demographics demonstrated determine Google form HCW HCWs Health healthcare Healthcare workers help hospital infection control Infection Control measures infections King National participant Patient Prevalence SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 infections Saudi Arabia Seropositivity Seroprevalence significantly higher social distancing Symptoms was used worker [DOI] 10.1016/j.jiph.2022.01.018 PMC 바로가기 [Article Type] Article
Seroprevalence of anti-SARS-CoV-2 antibodies in Africa: A systematic review and meta-analysis아프리카에서 항 SARS-CoV-2 항체의 혈청 유병률: 체계적인 검토 및 메타 분석Review Published on 2022-03-012022-09-12 Journal: Reviews in Medical Virology [Category] MERS, SARS, 진단, [키워드] acute respiratory syndrome affected Africa African age AMED anti-SARS-CoV-2 antibody antibody article CINAHL conducted coronavirus coronavirus disease country COVID-19 critical appraisal database East eligible evaluated Factors Gender Google Scholar heterogeneity highest human population Immunity individual male Meta-analysis North participant Prevalence PsycINFO reported SARS-CoV-2 SARS-COV-2 infection searched Seropositivity Seroprevalence Surveillance systematic review West [DOI] 10.1002/rmv.2271 PMC 바로가기 [Article Type] Review
Inflammatory but not respiratory symptoms are associated with ongoing upper airway viral shedding in outpatients with uncomplicated COVID-19호흡기 증상이 아닌 염증성 증상은 합병증이 없는 COVID-19 외래 환자에서 진행 중인 상기도 바이러스 배출과 관련이 있습니다.Clinical Trial Published on 2022-03-012022-09-11 Journal: Diagnostic microbiology and infectious disease [Category] SARS, 임상, 치료기술, [키워드] 14-18 95% confidence interval acute respiratory syndrome coronavirus airway approach approaches benefit characterized clinical trial Cohort coronavirus 2 coronavirus disease cough COVID-19 demonstrated enrolled Enrollment fatigue Fever greater hazard ratio implication Infection Inflammatory Lambda majority median time myalgias Oropharyngeal oropharyngeal viral shedding outpatients with uncomplicated peaked Placebo predictor respiratory respiratory symptom respiratory symptoms SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 RNA Seropositivity severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 significantly Symptom symptom clustering symptom onset symptom progression symptom resolution trajectory Trial viral shedding [DOI] 10.1016/j.diagmicrobio.2021.115612 PMC 바로가기 [Article Type] Clinical Trial
Evaluation of antibody response after COVID-19 vaccination of healthcare workers의료진의 코로나19 예방접종 후 항체반응 평가Article Published on 2022-03-012022-09-11 Journal: Journal of medical virology [Category] MERS, SARS, 진단, 치료법, [키워드] addition age antibody antibody levels Antibody Response antibody response against Antibody titer Antibody titers BMI BMI values body mass body mass index CoronaVac COVID-19 COVID-19 vaccination develop dose effective Elecsy Elecsys evaluated examined Factor female Gender HCW healthcare healthcare worker Healthcare workers immune response Immunity Inactivated vaccine individuals infected with COVID-19 interquartile range IQR male median age nucleocapsid protein obese participant Participants participated postvaccination RBD RBD protein Receptor binding Receptor binding domain Receptor-binding domain SARS-CoV-2 SARS-CoV-2 spike protein second dose second dose of vaccine Seropositivity Smokers smoking Spike protein the receptor-binding domain the SARS-CoV-2 U/mL Vaccine Volunteer volunteers was determined was measured [DOI] 10.1002/jmv.27420 PMC 바로가기 [Article Type] Article
Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients면역 억제 환자에서 SARS-CoV-2 백신 접종에 대한 세포 및 체액 반응Article Published on 2022-03-012022-09-11 Journal: Cellular immunology [Category] SARS, 치료기술, [키워드] Activation anti-spike antibodies B-cell BNT162b2 BNT162b2 mRNA CD8 ChAdOx1 ChAdOx1 nCoV-19 cohorts comparable COVID-19 cytokine Cytokines demonstrated depleting detectable difference Efficacy elicited haematological malignancies haematological malignancy healthy healthy volunteers highest Humoral response humoral responses immunodominance immunogenic immunological responses Immunophenotyping Immunosuppressed immunosuppressed patient immunosuppressed patients Immunosuppression immunosuppressive immunosuppressive therapy less Longevity Lower memory naïve no significant differences non-responder participant Participants Patient patients treated phenotype preserved protective immunity receiving renal responders response SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine SARS-CoV-2 vaccines seroconvert serological seropositive Seropositivity significant difference T-cell T-cell ELISpot T-cell Response T-cell responses Th1 cytokine therapy Transplant Vaccinations vaccine immunogenicity vaccine response vaccine responses were used [DOI] 10.1016/j.cellimm.2022.104501 PMC 바로가기 [Article Type] Article
Breakthrough SARS-CoV-2 infections among BBV-152 (COVAXIN®) and AZD1222 (COVISHIELD TM ) recipients: Report from the eastern state of IndiaBBV-152(COVAXIN®) 및 AZD1222(COVISHIELD TM ) 수혜자 사이의 획기적인 SARS-CoV-2 감염: 인도 동부 주에서 보고Article Published on 2022-03-012022-09-11 Journal: Journal of medical virology [Category] SARS, 변종, 치료기술, [키워드] acute respiratory syndrome Antibody titer Antibody titers Antigen AZD1222 be positive breakthrough Breakthrough infection breakthrough infections collected Complete coronavirus 2 coronavirus disease Coronavirus disease-19 COVAXIN® COVID-19 COVISHIELDTM detect dose healthcare facility highlight Home isolation Hospitalization hospitalized patients IgG titer value Immunity India individual interquartile range less median median age MONITOR Nasopharyngeal swab Older age Patient positive Postinfection Quantitative receiving Receptor binding domain recipient recipients report reported required respiratory SARS-CoV-2 SARS-COV-2 infection Seropositivity serum sample serum samples severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 significantly significantly higher Swab symptomatic vaccinated individual vaccinated individuals vaccination Vaccine Vaccine development Vaccines variant variants virus infection [DOI] 10.1002/jmv.27382 PMC 바로가기 [Article Type] Article